Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel GCK, HNFA1 and HNFA4 Mutations

• Autor(a) principal: Alvelos, Maria I.
• Data de Publicação: 2020
• Outros Autores: Gonçalves, Catarina I., Coutinho, Eduarda, Almeida, Joana T., Bastos, Margarida, Sampaio, Maria L., Melo, Miguel, Martins, Sofia, Dinis, Isabel, Mirante, Alice, Gomes, Leonor, Saraiva, Joana, Pereira, Bernardo D., Gama-de-Sousa, Susana, Moreno, Carolina, Guelho, Daniela, Martins, Diana, Baptista, Carla, Barros, Luisa, Ventura, Mara, Gomes, Maria M., Lemos, Manuel C.
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: http://hdl.handle.net/10316/106283; https://doi.org/10.3390/jcm9010288
• topic: diabetes; MODY; genetics; mutation

Maturity-onset diabetes of the young (MODY) is a frequently misdiagnosed type of diabetes, which is characterized by early onset, autosomal dominant inheritance, and absence of insulin dependence. The most frequent subtypes are due to mutations of the GCK (MODY 2), HNF1A (MODY 3), and HNF4A (MODY 1) genes. We undertook the first multicenter genetic study of MODY in the Portuguese population. The GCK, HNF1A, and HNF4A genes were sequenced in 46 unrelated patients that had at least two of the three classical clinical criteria for MODY (age at diagnosis, family history, and clinical presentation). The functional consequences of the mutations were predicted by bioinformatics analysis. Mutations were identified in 23 (50%) families. Twelve families had mutations in the GCK gene, eight in the HNF1A gene, and three in the HNF4A gene. These included seven novel mutations (GCK c.494T>C, GCK c.563C>G, HNF1A c.1623G>A, HNF1A c.1729C>G, HNF4A c.68delG, HNF4A c.422G>C, HNF4A c.602A>C). Mutation-positive patients were younger at the time of diagnosis when compared to mutation-negative patients (14.3 vs. 23.0 years, p = 0.011). This study further expands the spectrum of known mutations associated with MODY, and may contribute to a better understanding of this type of diabetes and a more personalized clinical management of affected individuals.